VIDEO: Gene therapy shows growing promise in treatment of retinal diseases

ByLejla Vajzovic, MD, FASRS

ByDavid W. Mullin

Fact checked byChristine Klimanskis, ELS

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, discusses the growing role of intravitreal and subretinal gene therapy in treating retinal diseases.

“All of these trials are showing us that gene therapy is definitely having a role in the treatment of common retinal diseases,” Vajzovic said. “Efficacy has proven to decrease the need for frequent injections for wet AMD and diabetic retinopathy, but also overall safety profiles are looking promising.”

Published by:

Sources/Disclosures

Collapse

Source:

Vajzovic L. Lessons learned in intravitreal, suprachoroidal and subretinal gene therapy: Maximizing efficacy and minimizing inflammation. Presented at: OSN New York and OSN New York Retina; Nov. 11-Nov. 13, 2022; New York.

Disclosures: Vajzovic reports being a lead investigator in several clinical trials investigating gene therapy, including Gyroscope Therapeutics and Regenxbio.

OSN New York and OSN New York Retina

Read more

VIDEO: Gene therapy shows growing promise in treatment of retinal diseases

Related Content